Digit Ratio (2D:4D) and cancer: What is known so far?
The ratio between the second and fourth digits is a proxy marker for prenatal exposure and sensitivity to sexual hormones, which can be genetically influenced. The influence of prenatal hormone exposure can reflect on adult life traits such as psychological traits, athletic performance and diseases such as cardiovascular. An important and newly explored field on digit ratio research is its correlation to different types of cancer, as a marker for prevalence and severity. In this review, the different types of cancer already correlated to digit ratios are discussed.
Cite this article as: Hopp RN, Lima N, Filho J, Sena-Filho M, Samuel RO, Amaral JG, Jorge J. Digit Ratio (2D:4D) and cancer: What is known so far? Int J Cancer Ther Oncol 2014; 2(1):020111.
Breedlove SM. Minireview: Organizational hypothesis: instances of the fingerpost. Endocrinology 2010; 151:4116-22.
Muller DC, Baglietto L, Manning JT, McLean C, Hopper JL, English DR, Giles GG, Severi G. Second to fourth digit ratio (2D:4D), breast cancer risk factors, and breast cancer risk: a prospective cohort study. Br J Cancer 2012; 107:1631-6.
Zheng Z, Cohn MJ. Developmental basis of sexually dimorphic digit ratios. Proc Natl Acad Sci U S A 2011; 108:16289-94.
Manning JT, Callow M, Bundred PE. Finger and toe ratios in humans and mice: implications for the aetiology of diseases influenced by HOX genes. Med Hypotheses 2003; 60:340-3.
Medland SE, Zayats T, Glaser B, Nyholt DR, Gordon SD, Wright MJ, Montgomery GW et al. A variant in LIN28B is associated with 2D:4D finger-length ratio, a putative retrospective biomarker of prenatal testosterone exposure. Am J Hum Genet 2010; 86:519-25.
Manning JT. Digit Ratio: A Pointer to Fertility, Behavior, and Health. Rutgers University Press; 2002.
Jung H, Kim KH, Yoon SJ, Kim TB. Second to fourth digit ratio: a predictor of prostate-specific antigen level and the presence of prostate cancer. BJU Int 2011; 107:591-6.
Oh JK, Kim KH, Jung H, Yoon SJ, Kim TB. Second to fourth digit ratio: its relationship with core cancer volume and Gleason score in prostate biopsy. Int Braz J Urol 2012; 38:611-9.
Rahman AA, Lophatananon A, Stewart-Brown S, Harriss D, Anderson J, Parker T et al. Hand pattern indicates prostate cancer risk. Br J Cancer 2011; 104:175-7.
Hopp RN, Jorge J. Right hand digit ratio (2D:4D) is associated with prostate cancer: Findings of an admixed population study. Journal of Solid Tumors 2012; 2: 22-25.
Waters M, Rebholz CM, Wood B, Kuske A, McIntyre M, Sartor O. Second to fourth digit ratio and prostate cancer severity. Prostate Cancer Prostatic Dis 2013; 16:107-10.
Garcia-Cruz E, Piqueras M, Huguet J, Ribal MJ, Vilaseca A, Gosalbez D et al. Higher second fourth digit ratio predicts higher incidence of prostate cancer in prostate biopsy. Arch Esp Urol 2012; 65:816-21.
Muller DC, Giles GG, Manning JT, Hopper JL, English DR, Severi G. Second to fourth digit ratio (2D:4D) and prostate cancer risk in the Melbourne Collaborative Cohort Study. Br J Cancer 2011; 105:438-40.
Auger J, Eustache F. Second to fourth digit ratios, male genital development and reproductive health: a clinical study among fertile men and testis cancer patients. Int J Androl 2011; 34:e49-58.
Brabin L, Roberts SA, Farzaneh F, Fairbrother E, Kitchener HC. The second to fourth digit ratio (2D:4D) in women with and without human papillomavirus and cervical dysplasia. Am J Hum Biol 2008; 20:337-41.
Nicolas Hopp R, Jorge J. Right hand digit ratio (2D:4D) is associated with oral cancer. Am J Hum Biol 2011; 23:423-5.
Nicolás Hopp R, de Souza Lima NC, Filho JL, Filho MS, Lima CS, Jorge J. Digit ratio (2D:4D) is associated with gastric cancer. Early Hum Dev 2013; 89:327-9.
Manning JT, Bundred PE, Newton DJ, Flanagan BF. The second to fourth digit ratio and variation in the androgen receptor gene. Evol Hum Behav 2003; 24: 399-405.
Manning JT, Bundred PE. The ratio of 2nd to 4th digit length: a new predictor of disease predisposition? Med Hypotheses 2000; 54:855-7.
Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet 1990; 335:939-40.
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.